Mark R. Li

MR

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2022

Affiliations

Mark R. Li is an author at Pfizer (United States) specializing in hematologic abnormalities, body composition changes, and sex marker changes.

Publications per year

2022–2022

1

Publications

1